Myriad Genetics, a US-listed biotech, has joined the $20m series E round for RainDance Technologies, a local gene-sequencing service provider. All of RainDance’s previous venture capital investors also participated in the round: Mohr Davidow Ventures, Quaker BioVentures, Alloy Ventures, Acadia Woods and Sectoral Asset Management. RainDance previously raised $37.5m in its D round in January…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
